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Introduction: Psychological stress may alter immune function by activating physiological stress pathways. Building
on our previous study, in which we report that stress management training led to an altered self-reported and
cortisol response to psychological stress in patients with rheumatoid arthritis (RA), we explored the effects of this
stress management intervention on the immune response to a psychological stress task in patients with RA.
Methods: In this study, 74 patients with RA, who were randomly assigned to either a control group or a group that
received short stress management training, performed the Trier Social Stress Test (TSST) 1 week after the
intervention and at a 9-week follow-up. Stress-induced changes in levels of key cytokines involved in stress and
inflammatory processes (for example, interleukin (IL)-6 and IL-8) were assessed.
Results: Basal and stress-induced cytokine levels were not significantly different in patients in the intervention and
control groups one week after treatment, but stress-induced IL-8 levels were lower in patients in the intervention
group than in the control group at the follow-up assessment.
Conclusions: In line with our previous findings of lower stress-induced cortisol levels at the follow-up of stress
management intervention, this is the first study to show that relatively short stress management training might also
alter stress-induced IL-8 levels in patients with RA. These results might help to determine the role of immunological
mediators in stress and disease.
Trial registration: The Netherlands National Trial Register (NTR1193)Introduction
Psychological stress may alter immune function by acti-
vating physiological pathways of stress, such as the auto-
nomic nervous system and the hypothalamus–pituitary–
adrenal axis, which in turn interact with the immune
system [1-4]. Consequently, stress could have negative
effects on health, particularly in populations with im-
mune dysfunction, such as patients with rheumatoid
arthritis (RA). The pathophysiological mechanisms in-
volved in stress and disease exacerbation have not yet
been elucidated.* Correspondence: Sabine.deBrouwer@radboudumc.nl
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distribution, and reproduction in any mediumPsychological responses to stress that might lead to
immune dysregulation can be altered by interventions
aimed at reducing psychological stress [1,5]. As yet there
is no consensus about whether and to what extent stress
management interventions are able to alter immune
function. In an extensive meta-analysis by Miller and
Cohen there was only modest evidence that different
types of stress management interventions change basal
immune function in healthy and clinical populations,
with most consistent changes being found in basal total
leukocyte counts and secretory immunoglobulin A levels
[6]. More recent studies reported that psychological in-
terventions for patients with HIV or cancer changed
basal lymphocyte proliferation and basal levels of proin-
flammatory cytokines [7-10]. Even though the effects of
psychological interventions in patients with RA haventral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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only incidental reports of immune changes after psycho-
logical interventions in patients with RA, such as changes
in interleukin (IL)-6 or interferon-gamma (IFNγ) [17,18],
or in immune measures indicative of disease status, such
as C-reactive protein and erythrocyte sedimentation rate
[19-24]. Potentially, previous effects in RA might be lim-
ited because changes in immune function in response to a
real-life stressor have not yet been investigated combining
both a stress management intervention and a stress induc-
tion paradigm. Particularly then, the benefits of stress
management training can become evident because patients
are challenged to cope with a stressful situation.
We previously showed that a short course of stress
management training decreased the subjective distress
response and stress-induced cortisol levels in patients
with RA at a follow-up assessment, and especially in
those patients psychologically at risk [5]. In the present
study, we explored the effects of the intervention on
stress-induced levels of key cytokines involved in disease
progression (for example, IL-6 and IL-8) in patients with
RA, with stress being elicited by the Trier Social Stress
Test. Building on our previous findings [5], we expected
that patients in the intervention group would show an
altered cytokine response to acute psychosocial stress
compared with controls at the 9-week follow-up assess-
ment. We also explored immune effects specifically in
patients psychologically at risk.
Materials and methods
This study was part of a larger trial for which the
methods and CONSORT statement have been described
extensively elsewhere [5]. The study protocol was ap-
proved by the regional medical ethics committee (CMO
Region Arnhem-Nijmegen) and was registered in The
Netherlands National Trial Register (NTR 1193). Writ-
ten informed consent was obtained from all participants.
Participants and procedure
Participants
Ninety-six eligible patients with RA [25] were random-
ized to one of two parallel groups: the control or the
intervention condition. After randomization, 19 partici-
pants withdrew before the first stress test and three
participants were excluded based on our predefined ex-
clusion criteria (that is, use of psychiatric medication). In
addition, seven out of 74 participants withdrew before the
second stress test. Reasons for withdrawal were physical
comorbidity, severe illness or death of a significant other,
a change in pharmacotherapy, or lack of motivation (for
more information on completers and dropouts, see the
flowchart in [5]). There were no differences in sociodemo-
graphic variables and psychological and physical function-
ing at baseline between the dropouts and the completers.For explorative subgroup analyses of patients psychologic-
ally at risk, participants were post hoc divided into two
subgroups using a median split of a composite score for
baseline anxiety and negative mood [5].
Study design
Participants performed a stress test 3 weeks after the
first assessment (post treatment) and 9 weeks thereafter
(follow-up). One-half of the participants had participated
in an individual stress management training program
between the first and second assessments. The control
group received care as usual. Stress test sessions were run
between 13:00 and 15:30 hours. Participants refrained
from using caffeine, alcohol, nicotine, or physical exercise
on the test day, and from eating 2 hours before the first
blood sample was drawn. Forty minutes before the stress
test, a venous catheter was inserted into the nondominant
arm and participants rested for 20 minutes. Blood sam-
ples were taken at baseline (that is, after 20 minutes
of rest), immediately after the stress test, and 20 and 60
minutes later (t = 0, t = 20, t = 40, and t = 80 minutes,
respectively).
Stress task
The Trier Social Stress Test is a standardized laboratory
stress task consisting of a mock job interview and men-
tal arithmetic, and induces self-reported, neuroendocrine,
and autonomic nervous system responses [26,27].
Stress management training
Participants in the intervention group received individual
stress management training as described previously [5].
The program consisted of four individual 1-hour sessions of
stress management with a trained therapist over 2 consecu-
tive weeks and included applied, progressive, cue-controlled,
and differential relaxation techniques, as well as psycho-
education, breathing and visualization exercises. After the
training, patients were encouraged to stick to a relapse-
prevention checklist during the 9-week follow-up period.
Measures
This study builds on a previous study [5], in which general
psychological (for example, anxiety), physical (28-joint
Disease Activity Score), autonomic (alpha-amylase) and
neuroendocrine (cortisol) outcomes are reported, by fur-
ther exploring immune responses to stress through meas-
urement of various circulating cytokines.
Cytokine assay
The blood samples that were collected during the two
stress tests (post treatment and follow-up) were stored
at –35°C until analysis. Based on the literature of psy-
chophysiological stress reactivity in healthy populations
and chronic inflammatory diseases, such as RA [1,28-30],
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and tumor necrosis factor alpha (TNFα) were measured
in serum using human cytokine multiple kits (Invitrogen
Corporation, Camarillo, CA, USA) according to the man-
ufacturer’s instructions. Samples were analyzed with a
Luminex® 100 TM instrument (Luminex Corporation,
Austin, TX, USA). The sensitivity of the cytokine
assay was <5 pg/ml for all cytokines measured. To reduce
error variance caused by between-run variation, all sam-
ples from one participant were analyzed in the same run.
Statistical analysis
Data for the 74 participants who completed the study
protocol were analyzed. Skewed data were logarithmic-
ally transformed to generate unskewed data distributions
before statistical analysis. Normal distributions and resid-
uals were not obtained after logarithmic transformation of
data for IL-5 and IFNγ levels. Between-group differences
in age, sex, education, and psychological measures at base-
line were tested with independent Student’s t tests and
chi-square analyses. Baseline cytokine levels (t = 0 mi-
nutes) were compared between intervention and control
groups with analyses of covariance. Cytokine responses to
the Trier Social Stress Test (post treatment and follow-up)
were evaluated using a linear mixed model taking into ac-
count the specific design features of the study. Cytokine
levels (IL-1β, IL-2, IL-4, IL-5, IL-6, IL-7, IL-8, IL-10, IFNγ,
and TNFα) were used as dependent variables; and group,
baseline measurement of the dependent variable (t = 0
minutes), and time (t = 20 minutes, t = 40, minutes,
and t = 80 minutes) were used as independent variables.
As group by time interactions were not observed, the final
model contained only main effects. Explorative subgroup
analyses were performed to test whether effects were par-
ticularly detected in patients psychologically at risk as
compared with patients not at risk [5] by incorporating
risk group and risk group by treatment interactions into
the models. A significant interaction was interpreted as in-
dicating that there were subgroup differences in the effect
of the treatment. Stratified analyses were performed to
gain a better understanding of the nature of the responses
in the patient subgroups. For each outcome measure, an
unstructured covariance matrix was used to model the
dependence between repeated measurements of the
dependent variable. Owing to (a tendency towards) an un-
equal sex distribution, use of hormonal contraceptives,
baseline anxiety scores, and the use of nonsteroidal anti-
inflammatory drugs across the two groups [5], all analyses
were performed with these four covariates.
Because participants dropped out mostly prior to the
first stress test (see previous section and [5]), and conse-
quently no stress test data were available for these
participants 1 week after treatment and at follow-up,
intention-to-treat analyses were not performed [31].In total, the data for the 74 patients (post treatment)
and 67 patients (follow-up) included in the analyses
were 85% complete, mainly because a venous catheter
could not be inserted in a number of patients during
one or both stress tests. Cytokines were significantly inter-
correlated with at least five to nine of the other cytokines,
and significant correlations ranged from 0.20 to 0.80. Un-
detectable levels (in percentage of available samples) of IL-
1β (33%), IL-2 (41%), IL-4 (37%), IL-5 (43%), IL-6 (27%),
IL-7 (41%), IL-8 (13%), IL-10 (25%), IFNγ (70%) and TNFα
(16%) were set to zero and included in all analyses. The
Bonferroni correction for multiple testing was not applied
due to the explorative nature of this study, the small sample
size, and the high intercorrelation of most cytokines, which
makes the method even more conservative than in other
applications [32]. Analyses were performed using SPSS 16.0
for Windows (SPSS Inc, Chicago, IL, USA). For all analyses,
the significance level was α = 0.05 (two-sided).
Results
Psychophysiological stress reactivity
Cytokine levels at baseline
Both after the intervention and at follow-up there were
no significant differences between the intervention and
control groups in baseline levels (t = 0 minutes) of all
cytokines (P >0.05) (Table 1 and Additional file 1).
Post-treatment stress-induced cytokine levels
Immediately after the intervention, stress-induced cyto-
kine levels were similar in the intervention and control
groups (group effect, P >0.10 for all cytokines), indicating
that patients in the intervention group did not have an al-
tered immune response to stress compared with patients
in the control group. Subgroup analyses also showed no
interaction between condition (intervention/control) and
psychological risk group (high/low) (P >0.20 for all cyto-
kines) (Table 1 and Additional file 1).
Follow-up stress-induced cytokine levels
At the follow-up assessment, stress-induced IL-8 levels
were significantly lower in patients in the intervention
group than in patients in the control group (group effect,
F(1, 54.273) = 5.421, P = 0.02) (Figure 1). Exploration of
IL-8 responses in subgroups of patients psychologically at
risk and not at risk showed a tendency towards an inter-
action effect between condition (intervention/control) and
risk group (high/low) (interaction effect, F(1, 51.990) =
3.244, P = 0.08), indicating that high-risk patients tended
to respond differently to stress management training than
low-risk patients. Post hoc tests revealed that IL-8 levels
were more decreased in high-risk patients in the interven-
tion group than in the low-risk intervention group. Omis-
sion of the data for patients with undetectable IL-8 levels
from analyses did not change the main result (group
Table 1 Baseline and stress-induced cytokine levels (pg/ml) in the intervention and control conditions post treatment
and at follow-up
t = 0 minutes t = 20 minutes t = 40 minutes t = 80 minutes
IL-1β
Post-treatment IC 92.39 (33.6) 106.7 (41.4) 111.3 (46.4) 111.6 (45.4)
CC 114.3 (38.6) 130.9 (43.5) 116.6 (37.0) 136.7 (59.0)
Follow-up IC 66.48 (18.8) 77.43 (23.7) 69.49 (20.1) 70.89 (19.9)
CC 119.0 (43.0) 100.7 (32.5) 98.13 (34.1) 117.6 (41.2)
IL-2
Post-treatment IC 28.11 (11.1) 30.85 (11.9) 34.83 (15.6) 31.58 (13.4)
CC 32.60 (14.0) 42.86 (19.2) 38.77 (17.3) 47.51 (27.0)
Follow-up IC 20.28 (7.20) 25.27 (10.3) 17.37 (7.23) 19.32 (7.15)
CC 35.89 (18.4) 27.82 (14.1) 28.12 (14.0) 32.24 (15.4)
IL-4
Post-treatment IC 48.22 (24.9) 48.30 (21.0) 48.98 (20.3) 52.90 (25.7)
CC 60.18 (29.3) 72.79 (30.1) 65.76 (28.4) 65.39 (29.9)
Follow-up IC 33.22 (13.9) 35.16 (14.9) 33.62 (12.6) 33.08 (13.6)
CC 56.48 (23.2) 51.79 (20.0) 50.91 (21.5) 56.99 (24.8)
IL-5
Post-treatment IC 20.94 (15.2) 21.89 (15.3) 23.24 (16.5) 21.49 (15.6)
CC 5.129 (2.17) 7.887 (3.72) 7.006 (2.94) 8.948 (4.51)
Follow-up IC 16.23 (12.8) 15.89 (12.1) 15.14 (12.1) 17.60 (14.5)
CC 7.368 (3.48) 6.048 (2.95) 5.929 (2.60) 6.969 (3.11)
IL-6
Post-treatment IC 36.46 (11.2) 34.94 (9.69) 38.80 (11.1) 40.36 (11.2)
CC 30.18 (9.36) 41.18 (15.2) 33.54 (10.7) 39.57 (16.2)
Follow-up IC 25.79 (7.51) 23.39 (7.90) 23.63 (6.41) 23.18 (6.68)
CC 31.20 (14.1) 30.18 (12.0) 29.22 (11.3) 30.43 (11.6)
IL-7
Post-treatment IC 70.11 (26.0) 70.27 (24.8) 73.62 (24.7) 69.51 (27.2)
CC 52.69 (16.5) 63.65 (20.5) 55.94 (18.5) 60.73 (21.8)
Follow-up IC 52.54 (23.4) 54.54 (23.5) 49.13 (19.6) 53.32 (22.2)
CC 52.80 (18.4) 53.69 (18.0) 48.64 (18.2) 52.89 (19.1)
IL-8
Post-treatment IC 22.14 (3.67) 16.19 (3.70) 17.02 (3.53) 14.47 (3.41)
CC 29.55 (6.50) 34.04 (7.81) 29.45 (6.75) 28.18 (7.14)
Follow-up IC 19.51 (4.28) 13.97 (4.67) 12.53 (4.00) 10.37 (3.38)a
CC 33.63 (6.68) 33.46 (8.33) 29.31 (7.83) 23.64 (5.72)
IL-10
Post-treatment IC 172.0 (75.2) 183.7 (81.0) 175.5 (80.0) 164.7 (75.8)
CC 49.33 (25.9) 57.07 (31.8) 73.55 (48.1) 71.02 (45.9)
Follow-up IC 72.67 (35.6) 115.6 (54.6) 85.90 (41.9) 78.49 (37.4)
CC 46.83 (26.8) 43.63 (24.2) 39.90 (20.9) 50.27 (28.0)
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Table 1 Baseline and stress-induced cytokine levels (pg/ml) in the intervention and control conditions post treatment
and at follow-up (Continued)
IFNγ
Post-treatment IC 1.063 (0.39) 1.070 (0.43) 0.821 (0.33) 0.706 (0.31)
CC 1.545 (0.45) 8.328 (4.98) 6.623 (4.91) 7.591 (5.70)
Follow-up IC 0.857 (0.39) 0.772 (0.32) 0.925 (0.36) 1.062 (0.38)
CC 4.389 (2.87) 8.535 (6.37) 6.597 (4.98) 7.377 (5,94)
TNFα
Post-treatment IC 31.40 (8.54) 34.98 (8.95) 34.82 (8.35) 35.60 (10.7)
CC 34.56 (12.4) 39.35 (12.7) 36.00 (11.1) 35.45 (11.2)
Follow-up IC 23.90 (5.75) 26.44 (6.94) 24.74 (5.89) 25.19 (6.44)
CC 26.26 (8.74) 23.84 (7.17) 25.04 (9.44) 25.93 (8.92)
Data presented as mean (± standard error of the mean). CC, control condition; IC, intervention condition; IFNγ, interferon gamma; IL, interleukin; TNFα, tumor
necrosis factor alpha. aSignificant between-group effect (P ≤0.05). Means at the four time points. Statistical analyses performed on ln-transformed data.
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tients still showed a (significantly) different response to
the training than low-risk patients (interaction effect con-
dition and risk status, F(1, 46.212) = 4.472, P = 0.04). For
all other cytokines, there were no significant differ-
ences in levels after stress induction between the inter-
vention and control groups at follow-up (P >0.10) (Table 1
and Additional file 1).
Discussion
This is the first study to explore the response of circulat-
ing cytokines to a psychosocial stress test after stress
management training in patients with RA. Although no
differences in basal and stress-induced levels of key cyto-
kines were observed immediately after the intervention,
patients in the intervention group had lower stress-
induced IL-8 levels than patients in the control group at
the follow-up assessment. Results suggest that a short
individual training in stress management might alterFigure 1 Interleukin-8 response to stress. Mean ± standard error of the
Trier Social Stress Test (TSST)), t = 20 minutes, t = 40 minutes, and t = 80 m
control conditions (CC) immediately after the intervention (left: IC, n = 35; Cimmune parameters after a psychosocial stress task in a
population with immune dysfunction; namely, patients
with RA. This finding is in line with our previous report
indicating that the stress management training improves
psychological functioning and influences subjective and
endocrine parameters of stress (that is, distress and cor-
tisol levels) at the follow-up assessment [5].
Stress-induced immune effects after a stress manage-
ment intervention have not so far been investigated in
rheumatic patients, including patients with RA. Stress
induction paradigms using only a single stress exposure
have yielded relatively robust effects on IL-6, IL-1β, and
IFNγ levels in various healthy and patient populations
[28,29]. Stress exposure also changes levels of these and
other cytokines in rheumatic patients, but results are
much less consistent [2]. For example, IL-6 levels in-
creased in response to a cold pressor task in patients with
RA and juvenile idiopathic arthritis [33,34], but IL-6 and
IFNγ levels remained unchanged after psychological stressmean interleukin (IL)-8 levels (pg/ml) at t = 0 minutes (baseline/pre
inutes (post TSST) of patients in the intervention conditions (IC) and
C, n = 32) and at follow-up (right: IC, n = 33; CC, n = 28).
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thematosus [35-37]. Differences in stress induction para-
digms and detection methods used and differences in the
heterogeneity of patient samples might explain the incon-
sistent findings. Immune function after stress manage-
ment training has only been measured incidentally in
patients with RA and, moreover, has not been investigated
in combination with stress exposure. One study reported
altered basal IFNγ levels after emotional disclosure ther-
apy for patients with RA [17], while lower basal IL-6 levels
were observed after cognitive behavioral therapy com-
pared with meditation and education groups [18]. Several
other studies also reported other types of biological
markers, mostly erythrocyte sedimentation rate and/or C-
reactive protein, often as part of assessing overall disease
activity, but did not find intervention-related changes
[21,22,24,38-46]. In our study, the stress management
intervention did not change basal or stress-induced cyto-
kine levels, except for a decrease in stress-induced IL-8
levels at follow-up.
Chemotactic IL-8 is a key player in the acute exacerba-
tion of inflammatory conditions, directing neutrophils
and other cell types (for example, monocytes and lym-
phocytes) to sites of inflammation when homeostasis is
disrupted [47]. Blocking the actions of IL-8 has been
shown to prevent acute inflammation in animal models
[48]. The lipopolysaccharide-stimulated production of
IL-8 has been found to be positively correlated with per-
ceived stress in healthy adults, and this could be primar-
ily attributed to negative affect [49,50]. However, IL-8
levels did not change after the induction of stress with
the cold pressor task in patients with juvenile idiopathic
arthritis and healthy controls [34]. Whether IL-8 acts
as a more general marker of stress or whether it is
specifically involved in the physiological stress re-
sponse of patients with RA is not yet clear. Conse-
quently, future studies should compare IL-8 responses
to stress and stress management training in both
healthy and clinical populations. Interestingly, the ef-
fect of the stress management training on stress-
induced IL-8 levels tended to be particularly evident
in patients with heightened levels of anxiety and
negative mood. We found comparable effects for self-
reported levels of tension and cortisol levels in our
previous report [5], but these measures were not re-
lated to IL-8 levels in this study. In addition, the ef-
fectiveness of psychological treatment for RA patients
at risk was reported previously [51], which warrants
further research into the benefits of stress manage-
ment on different types of psychophysiological param-
eters in high-risk patients.
This study had several limitations. The relatively homo-
geneous and small sample of patients with mild RA pre-
vents generalization of our findings. The normal range formany immune parameters is very broad and psychological
interventions, especially of short duration, might not in-
duce physiological changes of sufficient magnitude or
duration to move cytokine levels beyond this range [6].
Nevertheless, intervention studies have demonstrated that
immune alterations occur when people display a change in
cognition [52] and emotion [7]. Moreover, intervention-
related immune changes could have been masked by
biological forces, such as disease flare-ups and biological
treatments that affect the patients’ immune system [6]. Al-
though we tried to limit effects of disease flare-ups by
monitoring the patients’ disease status and ruled out that
treatment effects were caused by differences in biological
treatment protocols through covariate analyses, we cannot
preclude that this problem might have influenced our re-
sults. Prompted by earlier unequivocal findings of stress-
induced changes to immune function in rheumatic pa-
tients [2], the high intercorrelation of most cytokines, and
the small sample size, Bonferroni correction for multiple
testing was not applied in this explorative study. Future re-
search should try to replicate our findings and, if possible,
apply the Bonferroni correction to data with large sample
sizes. Moreover, the direction of other cytokine responses
observed in this study (for example, IFNγ) seems consist-
ent with the stress literature and tentatively suggests a
broader effect of stress management training on immune
function, but larger studies are needed to validate this
effect. Furthermore, no statements can be made about the
clinical relevance of our results, especially since the inter-
vention was of short duration (four 1-hour sessions over 2
weeks) and disease activity did not improve over the course
of our study [5]. A longer intervention that may produce
more pronounced effects might overcome these problems.
Another general problem concerning immune markers in
stress research, particularly circulating cytokines, is the
ambiguity regarding the interpretation of findings. Circulat-
ing levels of cytokines are thought to reflect levels of sys-
temic inflammation and are correlated with disease activity
and radiographic progression [53]; however, changes in
cytokine concentrations from baseline might not indicate
de novo cytokine production or clearance, but a redistribu-
tion of existing cytokines from or into the periphery
[54]. To what extent these alterations represent adap-
tive or maladaptive immune processes is not well
understood and needs further investigation.
Conclusions
Patients with RA who received training in stress manage-
ment not only show changes in the subjective and cortisol
response to stress [5], but might also be characterized by
an altered immune response to stress; that is, lower IL-8
levels. Although results of this and our previous study
need validation in larger studies, they provide preliminary
evidence that a short psychological intervention is not
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acts on the neuroendocrine and immune systems and
therefore might have the potential to ameliorate the pos-
sible harmful effects of stress on health in patients with
RA. Stress management training might prove to be benefi-
cial as an adjunct to standard therapy to control arthritis
symptoms.
Additional file
Additional file 1: is Figure S1 showing the mean response to stress
of (A) IL-1β, (B) IL-2, (C) IL-4, (D) IL-5, (E) IL-6, (F) IL-7, (G) IL-8, (H) IL-10,
(I) IFNγ, and (J) TNFα (in pg/ml ± standard error of the mean) at t = 0
minutes (baseline/pre TSST), t = 20 minutes, t = 40 minutes, and
t = 80 minutes (post TSST) for patients in the intervention condition
(IC) and control condition (CC) immediately after the intervention
(post; red) and at follow-up (FU; blue).
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